Has Daniel Dibardino, MD received payments from drug or device companies?

Yes. Drug and device makers reported $89,332 in general payments to Daniel Dibardino, MD across 379 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Daniel Dibardino, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Daniel Dibardino, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Daniel Dibardino, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Toledo, OHNPI 1194904334

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (43.4%), travel and lodging and education — rather than concentrated in one kind of arrangement. ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) accounts for 61.8% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2023 at $32,846 and has fallen 62.2% since, to $12,409 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$89,332in general payments, 2019–2025

Across 379 payments — averaging $235.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$55K
Zimmer Biomet$24K
Atricure, Inc.$5K
Edwards Lifesciences$2K
Medtronic$785
Abiomed$437
plus $2K from 20 others

What the payments were for

Consulting fees$6,0007%
Speaking & faculty fees$38,75043%
Travel & lodging$21,70324%
Food & beverage$8,84710%
Education$14,03216%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	132	$55,221
Zimmer Biomet	52	$24,394
Atricure, Inc.	42	$4,566
Edwards Lifesciences	37	$2,206
Medtronic(2 entities)	47	$785
Abiomed	8	$437
Inari Medical, Inc.	8	$273
Artivion, Inc.	5	$265
Abbott	5	$238
Johnson & Johnson(2 entities)	13	$220
Davol Inc.	3	$191
KCI USA, Inc.	5	$86
Livanova USA, Inc.	1	$62
Kls-martin L.p.	4	$53
LSI Solutions Inc	2	$50
Avanos Medical	2	$42
Stryker	1	$41
Novartis	2	$40
Boston Scientific	2	$38
Lemaitre Vascular, Inc.	1	$25
Solventum Corporation	1	$21
Intuitive Surgical	2	$20
Boehringer Ingelheim	1	$18
Pfizer	1	$16
E.r. Squibb & Sons, L.L.C.	1	$13
Elutia, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LifeVest$53,918
STERNALOCK 360 SYSTEM$8,290
STERNALOCK$6,500
SYNERGY ABLATION SYSTEM$2,700
CMF & Thoracic-None$1,000
ATRICLIP LAA EXCLUSION SYSTEM$933
ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2)$933
CMF & Thoracic Product Portfolio$735
INSPIRIS RESILIA aortic valve$616
STERNALOCK BLU SYSTEM$593
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$541
Carpentier-Edwards Physio II Annuloplasty Ring$304
EDWARDS INTUITY Elite valve system$259
Impella$248
MC3 NAUTILUS(TM) ECMO OXYGENATOR$166
MitraClip$152
SynerGraft$121

How this compares

$89,332 in reported general payments places this provider in the 90th percentile of 245 thoracic surgery (cardiothoracic vascular surgery) providers in Ohio.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Ohio →

Medicare billing

Part B allowed, 2024

$109,970

Medicare patients

Services billed

146

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Amiodarone Hcl	22	$307
ClopidogrelClopidogrel Bisulfate	42	$287
Atorvastatin Calcium	33	$172
Tamsulosin Hcl	11	$112
Metoprolol Tartrate	39	$95
Oxycodone Hcl	16	$63
Furosemide	13	$46

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Toledo

Michael MorontToledo$543K
Christopher PhillipsToledo$37K
Matthew GoodwinToledo$32K
Alejandro BribriescoCleveland$968K
Daniel WatsonColumbus$946K
Alan Marc GillinovCleveland$926K
Edward SolteszCleveland$835K
Eric OkumColumbus$637K
Desmond DsouzaColumbus$487K
Salil DeoCleveland$419K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →